|
Nkgen Biotech Inc (NASDAQ: NKGN) |
|
Nkgen Biotech Inc
NKGN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Nkgen Biotech Inc 's sales fell
in II. Quarter 2024 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 12.07 %
Nkgen Biotech Inc net loss increased from $-2 millions, to $-32 millions in II. Quarter 2024,
• More on NKGN's Growth
|
|
Nkgen Biotech Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 14.84 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.3.
• More on NKGN's Valuation
|
|
|
|
|
Nkgen Biotech Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 14.84 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.3.
• More on NKGN's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com